Navigation Links
Hologic to Participate in Four Investor Conferences
Date:7/14/2011

BEDFORD, Mass., July 14, 2011 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) today announced that company management will participate in the following conferences:

  • Deborah Gordon, Vice President, Investor Relations, will host investor meetings at the Lazard Capital Markets Corporate Access Day in Chicago, Illinois on Tuesday, August 9, 2011. Management will not be presenting at this conference.
  • Glenn Muir, Executive Vice President and Chief Financial Officer, will present at the 2011 Canaccord Genuity Growth Conference in Boston, Massachusetts on Wednesday, August 10, 2011 at 4:00 p.m. (Eastern).
  • Glenn Muir will present at the Stifel Nicolaus Annual Healthcare Conference in Boston, Massachusetts on Wednesday, September 7, 2011 at 10:55 a.m. (Eastern).
  • Rob Cascella, President and Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Conference in New York City, New York on Tuesday, September 13, 2011 at 3:55 p.m. (Eastern).

  • Interested parties are invited to listen to the live audio webcasts of the investor presentations on the investor section of Hologic's website at www.hologic.com/investors-overview. Archives of the presentations will be available for replay following the conferences.

    About Hologic, Inc.Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, breast Magnetic Resonance Imaging, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia and uterine fibroids, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications. For more information, visit www.hologic.com.Contact:

    Deborah GordonVice President, Investor RelationsHologic, Inc.(781) 999-7716
    '/>"/>

    SOURCE Hologic, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Hologic to Release Third Quarter Fiscal 2011 Operating Results on Monday, August 1, 2011
    2. Hologic Acquires TCT International Co. Ltd., a Leading Distributor of Medical Products in China
    3. Hologic Features New Minimally Invasive Technologies at the American Congress of Obstetricians and Gynecologists Annual Meeting
    4. Hologic Announces Second Quarter Fiscal 2011 Operating Results
    5. Hologic to Release Second Quarter Fiscal 2011 Operating Results on Monday, May 2, 2011
    6. Hologic, Hospira, Boston Scientific, Allergan to Participate in Leading Medical Device Manufacturing Symposium
    7. High Rates of Pathological Complete Response in Patients with Advanced Esophageal Cancer in OPAXIO™ Phase II Study Reported in American Journal of Clinical Oncology
    8. Hologic Targets Womens Health Professionals at ECR 2011
    9. FDA Approves Hologics Makena™ (Formerly Referred to as Gestiva™) Pharmaceutical
    10. Hologic Announces First Quarter Fiscal 2011 Operating Results
    11. Hologic Appoints Mark D. Myslinski as Senior Vice President and General Manager of Diagnostics
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: ... that developed an innovative way to use nonlinear optical ... delivery of new drugs. ... Dermatology Conference will show how researchers from BioPharmX and ... Medical School used a suite of imaging techniques in ...
    (Date:10/11/2017)... 11, 2017  True Health, a leader in ... effort during National Breast Cancer Awareness month to ... Research recently ... that more than 10 million American women are ... BRCA1 or BRCA2 and have not had testing. These ...
    (Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
    Breaking Medicine Technology:
    (Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
    (Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized health ... expanded their existing home health joint venture through an agreement, effective October 1, ... joint venture home health company with Asante, delivering clinically integrated care, for the ...
    (Date:10/12/2017)... ... October 12, 2017 , ... HMP , a ... of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners ... October 11, 2017. , The annual award competition recognizes editorial and design excellence across ...
    (Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand ... Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be ... Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection ...
    (Date:10/12/2017)... ... October 12, 2017 , ... ... wound care advancements to physician colleagues, skilled nursing facility medical directors and other ... Treacherous Waters of Wound Care." , "At many of these conferences we get ...
    Breaking Medicine News(10 mins):